130 related articles for article (PubMed ID: 23294798)
1. Online, direct-to-consumer access to insulin: patient safety considerations and reform.
Lovett KM; Liang BA; Mackey TK
J Diabetes Sci Technol; 2012 Nov; 6(6):1503-6. PubMed ID: 23294798
[TBL] [Abstract][Full Text] [Related]
2. Digital danger: a review of the global public health, patient safety and cybersecurity threats posed by illicit online pharmacies.
Mackey TK; Nayyar G
Br Med Bull; 2016 Jun; 118(1):110-26. PubMed ID: 27151957
[TBL] [Abstract][Full Text] [Related]
3. Illicit online marketing of lorcaserin before DEA scheduling.
Liang BA; Mackey TK; Archer-Hayes AN; Shinn LM
Obesity (Silver Spring); 2013 May; 21(5):861-4. PubMed ID: 23512816
[TBL] [Abstract][Full Text] [Related]
4. Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providers.
Findlay SD
Pharmacoeconomics; 2001; 19(2):109-19. PubMed ID: 11284378
[TBL] [Abstract][Full Text] [Related]
5. Direct-to-consumer prescription drug advertising: trends, impact, and implications.
Wilkes MS; Bell RA; Kravitz RL
Health Aff (Millwood); 2000; 19(2):110-28. PubMed ID: 10718026
[TBL] [Abstract][Full Text] [Related]
6. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.
Kim H
Int J Health Policy Manag; 2015 Aug; 4(12):813-21. PubMed ID: 26673465
[TBL] [Abstract][Full Text] [Related]
7. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay.
Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK
Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746
[TBL] [Abstract][Full Text] [Related]
8. Establishing a Link Between Prescription Drug Abuse and Illicit Online Pharmacies: Analysis of Twitter Data.
Katsuki T; Mackey TK; Cuomo R
J Med Internet Res; 2015 Dec; 17(12):e280. PubMed ID: 26677966
[TBL] [Abstract][Full Text] [Related]
9. Riskier than we think? The relationship between risk statement completeness and perceptions of direct to consumer advertised prescription drugs.
Davis JJ
J Health Commun; 2000; 5(4):349-69. PubMed ID: 11191018
[TBL] [Abstract][Full Text] [Related]
10. The Conundrum of Online Prescription Drug Promotion Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
Wanasika I
Int J Health Policy Manag; 2016 Mar; 5(6):391-2. PubMed ID: 27285519
[TBL] [Abstract][Full Text] [Related]
11. A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising.
Frosch DL; Grande D; Tarn DM; Kravitz RL
Am J Public Health; 2010 Jan; 100(1):24-32. PubMed ID: 19910354
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical companies and their drugs on social media: a content analysis of drug information on popular social media sites.
Tyrawski J; DeAndrea DC
J Med Internet Res; 2015 Jun; 17(6):e130. PubMed ID: 26032738
[TBL] [Abstract][Full Text] [Related]
13. The Tip of the Iceberg of Misleading Online Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
Mintzes B
Int J Health Policy Manag; 2016 Feb; 5(5):329-31. PubMed ID: 27239883
[TBL] [Abstract][Full Text] [Related]
14. Digital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
Mackey TK
Int J Health Policy Manag; 2016 Feb; 5(4):271-4. PubMed ID: 27239871
[TBL] [Abstract][Full Text] [Related]
15. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: Teaching Drug Marketers How to Inform Better or Spin Better? Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
Doran E
Int J Health Policy Manag; 2016 Feb; 5(5):333-5. PubMed ID: 27239884
[TBL] [Abstract][Full Text] [Related]
16. Direct-to-consumer advertising affects provider / patient relationship.
Contracept Technol Update; 1998 Dec; 19(12):153-5. PubMed ID: 12321805
[TBL] [Abstract][Full Text] [Related]
17. Don’t Try This at Home: the FDA’s Restrictive Regulation of Home Testing Devices.
Baird S
Duke Law J; 2017 Nov; 67(2):383-426. PubMed ID: 29469551
[TBL] [Abstract][Full Text] [Related]
18. A 3-stage model for assessing the probable economic effects of direct-to-consumer advertising of pharmaceuticals.
Vogel RJ; Ramachandran S; Zachry WM
Clin Ther; 2003 Jan; 25(1):309-29. PubMed ID: 12637129
[TBL] [Abstract][Full Text] [Related]
19. A decade of direct-to-consumer advertising of prescription drugs.
Donohue JM; Cevasco M; Rosenthal MB
N Engl J Med; 2007 Aug; 357(7):673-81. PubMed ID: 17699817
[TBL] [Abstract][Full Text] [Related]
20. Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis.
Adams C
J Med Internet Res; 2016 Feb; 18(2):e33. PubMed ID: 26892749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
